Indivior Pharmaceuticals (INDV) Net Income (2024 - 2026)
Indivior Pharmaceuticals (INDV) recorded Net Income of $122 million in Q2 2026, up 577.8% from $18 million a year earlier and up 37.1% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Net Income (2024 - 2026) Analysis & Trends
On a TTM basis, Indivior Pharmaceuticals' Net Income came in at $355 million as of Jun 30, 2026, up 225.7% year-over-year; for FY2025, it came in at $210 million.
- Annual Net Income has a four-year compound annual growth rate of 0.6% (FY2021 to FY2025).
- Across earlier years, Net Income came in at $7 million in FY2024 (+250.0%), $2 million in FY2023, -$53 million in FY2022 and $205 million in FY2021.
- The Q2 2026 figure is the highest quarterly Net Income in data going back to Q1 2024.
- On a year-over-year basis, Net Income has increased for four consecutive quarters, with growth averaging 223.4% over the last five quarters.
- Per Business Quant, the preceding three quarters came in at $89 million (Q1 2026), $102 million (Q4 2025) and $42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Indivior Pharmaceuticals | 4.32 Bn | 3.28 Bn | 294.00 Mn | 122.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 122.00 Mn |
| Mar 31, 2026 | 89.00 Mn |
| Dec 31, 2025 | 102.00 Mn |
| Sep 30, 2025 | 42.00 Mn |
| Jun 30, 2025 | 18.00 Mn |
| Mar 31, 2025 | 48.00 Mn |
| Dec 31, 2024 | 21.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | -98.00 Mn |
| Mar 31, 2024 | 62.00 Mn |
API Access
Indivior Pharmaceuticals Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();